Lipella Pharmaceuticals Inc. Common Stock

LIPO

...

LIPO: Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's lead product candidates include LP-10 and LP-310.

Show LIPO Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of LIPO by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

No Whale Activity for this ticker

Institutional Holdings Dashboard

Insider Trading

Quarterly net insider trading by LIPO's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

Patent Title: Delivery of agents using metastable liposomes Jun. 14, 2022
Patent Title: Delivery of agents using metastable liposomes May. 05, 2020

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on LIPO's company Twitter account

WallStreetBets

Number of mentions of LIPO in WallStreetBets Daily Discussion

LIPO News

Recent insights relating to LIPO

CNBC Recommendations

Recent picks made for LIPO stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in LIPO

Corporate Flights

Flights by private jets registered to LIPO